Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Crescent Biopharma Inc., 3 years.
Crescent Biopharma Inc.
Director
Oncolytics Biotech Inc.
Director
Geron Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +35,400 | $0.86 | $30,444 |
| Dec 29, 2023 | Crescent Biopharma Inc. | Grant or award | +5,191 | $2.36 | $12,251 |
| Sep 30, 2023 | Crescent Biopharma Inc. | Grant or award | +8,167 | $1.50 | $12,251 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.